Chondromodulin-I and tenomodulin are differentially expressed in the avascular mesenchyme during mouse and chick development.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 18239943)

Published in Cell Tissue Res on February 01, 2008

Authors

Chisa Shukunami1, Aki Takimoto, Shigenori Miura, Yuriko Nishizaki, Yuji Hiraki

Author Affiliations

1: Department of Cellular Differentiation, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan. shukunam@frontier.kyoto-u.ac.jp

Articles by these authors

Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol (2006) 2.31

Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med (2006) 2.03

Genetic variants in GPR126 are associated with adolescent idiopathic scoliosis. Nat Genet (2013) 1.90

Metre-long cell-laden microfibres exhibit tissue morphologies and functions. Nat Mater (2013) 1.44

Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Invest (2010) 1.42

Scx+/Sox9+ progenitors contribute to the establishment of the junction between cartilage and tendon/ligament. Development (2013) 1.26

Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues. Biochem Biophys Res Commun (2005) 1.24

Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. J Rheumatol (2003) 1.23

Suppression of differentiation and proliferation of early chondrogenic cells by Notch. J Bone Miner Metab (2003) 1.21

Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. J Cell Sci (2004) 1.16

Local tenomodulin absence, angiogenesis, and matrix metalloproteinase activation are associated with the rupture of the chordae tendineae cordis. Circulation (2008) 1.03

Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors. Cancer Res (2004) 1.00

Tead proteins activate the Foxa2 enhancer in the node in cooperation with a second factor. Development (2005) 1.00

Chondromodulin I is a bone remodeling factor. Mol Cell Biol (2003) 0.97

Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells. J Cell Sci (2007) 0.96

Chondromodulin-I and tenomodulin: the negative control of angiogenesis in connective tissue. Curr Pharm Des (2007) 0.96

Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes. Invest Ophthalmol Vis Sci (2003) 0.94

Direct conversion of tenocytes into chondrocytes by Sox9. Exp Cell Res (2012) 0.93

Immobilization of bioactive fibroblast growth factor-2 into cubic proteinous microcrystals (Bombyx mori cypovirus polyhedra) that are insoluble in a physiological cellular environment. J Biol Chem (2007) 0.89

Cartilaginous features in matrix-producing carcinoma of the breast: four cases report with histochemical and immunohistochemical analysis of matrix molecules. Mod Pathol (2008) 0.89

Immunohistochemical evaluation of cartilage-derived morphogenic protein-1 and -2 in normal human salivary glands and pleomorphic adenomas. Virchows Arch (2003) 0.87

Impairment of VEGF-A-stimulated lamellipodial extensions and motility of vascular endothelial cells by chondromodulin-I, a cartilage-derived angiogenesis inhibitor. Exp Cell Res (2009) 0.86

Tenomodulin expression in the periodontal ligament enhances cellular adhesion. PLoS One (2013) 0.85

Differential actions of VEGF-A isoforms on perichondrial angiogenesis during endochondral bone formation. Dev Biol (2009) 0.83

Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells. Mol Pharmacol (2009) 0.83

Generation and characterization of ScxCre transgenic mice. Genesis (2013) 0.83

Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: relationship with angiogenic factors in the cartilage. Acta Histochem (2002) 0.83

Pax1 acts as a negative regulator of chondrocyte maturation. Exp Cell Res (2013) 0.82

Transcriptome analysis of early chondrogenesis in ATDC5 cells induced by bone morphogenetic protein 4. Genomics (2004) 0.82

A functional role of the glycosylated N-terminal domain of chondromodulin-I. J Bone Miner Metab (2010) 0.82

Suppression of T cell responses by chondromodulin I, a cartilage-derived angiogenesis inhibitory factor: therapeutic potential in rheumatoid arthritis. Arthritis Rheum (2004) 0.80

Analyses of early events during chondrogenic repair in rat full-thickness articular cartilage defects. J Bone Miner Metab (2009) 0.80

Synthetic disulfide-bridged cyclic peptides mimic the anti-angiogenic actions of chondromodulin-I. Cancer Sci (2012) 0.79

Expression and localization of cartilage-specific matrix protein chondromodulin-I mRNA in salivary pleomorphic adenomas. Virchows Arch (2004) 0.78

Active proliferation of mesenchymal cells prior to the chondrogenic repair response in rabbit full-thickness defects of articular cartilage. Osteoarthritis Cartilage (2004) 0.78

Altered fracture callus formation in chondromodulin-I deficient mice. Bone (2008) 0.78

Expression of marker genes during otolith development in medaka. Gene Expr Patterns (2007) 0.77

Nondestructive micro-patterning of proteinous occlusion bodies in water by femtosecond laser-induced mechanical force. Biomed Microdevices (2007) 0.77

[Chondromodulin-I and its related gene Tenomodulin]. Clin Calcium (2002) 0.76

Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells. J Bone Miner Metab (2010) 0.76

Phenotypic switching of in vitro mandibular condylar cartilage during matrix mineralization. Anat Sci Int (2002) 0.76

Localization of chondromodulin-I at the feto-maternal interface and its inhibitory actions on trophoblast invasion in vitro. BMC Cell Biol (2011) 0.75

[Differentiation of cartilage stem cells and their clinical applications]. Clin Calcium (2002) 0.75

[Regeneration of cartilage/bone defects by growth/differentiation factors]. Nihon Ronen Igakkai Zasshi (2002) 0.75